Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 10/20 | 0.58 |
| ▸ | FLT3 | P36888 | 3/20 | 0.39 |
| ▸ | CDK2 | P24941 | 3/20 | 0.39 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.39 |
| ▸ | ACACB | O00763 | 5/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.35 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.35 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.35 |
| ▸ | CDK4 | P11802 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4719558 | 0.94 | GPR119 (0.57) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL4719427 | 0.90 | GPR119 (0.59) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL4718845 | 0.89 | GPR119 (0.63) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL389521 | 0.89 | GPR119 (0.73) | GPR119CYP2C9 | |
| SCHEMBL4720557 | 0.87 | GPR119 (0.61) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL4720463 | 0.87 | GPR119 (0.49) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL4720782 | 0.86 | GPR119 (0.58) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL4722205 | 0.85 | GPR119 (0.59) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL4721558 | 0.85 | GPR119 (0.53) | GPR119FLT3CDK2CDK6ACACB | |
| SCHEMBL4721951 | 0.85 | GPR119 (0.58) | GPR119CDK2CCNA2CDK5CDK5R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1756084-B1 | SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2008-11-26 | — | — | EP | claimed |